A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: Results of the GETUG S99 multicenter prospective studyKarim Fizazi, A. Laplanche, R. Delva et al.|Journal of Clinical Oncology|2009Cited by 2